Literature DB >> 11249206

Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes.

M E Quevedo1, A Slominski, W Pinto, E Wei, J Wortsman.   

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis is the major stress response system. Several components of the HPA axis, such as corticotropin-releasing hormone (CRH) and POMC peptides and their receptors are also present in the skin. In earlier studies, we showed that CRH inhibits cellular proliferation of immortalized human keratinocytes. We now examine further the functional activity of the HPA axis in the skin, by characterizing the actions of CRH on normal foreskin keratinocytes. The CRH receptor was detected as CRH-R1 antigen at 47 kDa in the cultured keratinocytes by Western blotting, and immunohistochemistry demonstrated its presence in the epidermal and follicular keratinocytes. CRH is also biologically active in cultured keratinocytes, where it inhibits proliferation and enhances the interferon-gamma-stimulated expression of the hCAM and ICAM-1 adhesion molecules and of the HLA-DR antigen. These effects were concentration-dependent, with maximal activity at CRH 10(-7) M. Thus, in the keratinocyte, the most important cellular component of the epidermis, CRH appears to induce a shift in energy metabolism away from proliferation activity, and toward the enhancement of immunoactivity. Therefore, similar to its central actions, cutaneous CRH may also he involved in the stress response, but at a highly localized level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11249206     DOI: 10.1290/1071-2690(2001)037<0050:peocrh>2.0.co;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  22 in total

Review 1.  Corticotropin releasing factor receptors and their ligand family.

Authors:  M H Perrin; W W Vale
Journal:  Ann N Y Acad Sci       Date:  1999-10-20       Impact factor: 5.691

2.  Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes.

Authors:  A T Slominski; B Roloff; B Zbytek; E T Wei; K Fechner; J Curry; J Wortsman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-03       Impact factor: 2.416

3.  Anti-inflammatory activity of corticotropin releasing factor: II. Mechanisms of action.

Authors:  J G Kiang; L Poree; E T Wei
Journal:  Proc West Pharmacol Soc       Date:  1987

Review 4.  Mechanism of action of cytokines to induce the pattern of pituitary hormone secretion in infection.

Authors:  S M McCann; K Lyson; S Karanth; M Gimeno; N Belova; A Kamat; V Rettori
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

Review 5.  Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.

Authors:  A Slominski; J Wortsman; T Luger; R Paus; S Solomon
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

Review 6.  Neuroendocrinology of the skin.

Authors:  A Slominski; J Wortsman
Journal:  Endocr Rev       Date:  2000-10       Impact factor: 19.871

7.  Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin.

Authors:  B Roloff; K Fechner; A Slominski; J Furkert; V A Botchkarev; S Bulfone-Paus; J Zipper; E Krause; R Paus
Journal:  FASEB J       Date:  1998-03       Impact factor: 5.191

8.  Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.

Authors:  T C Theoharides; L K Singh; W Boucher; X Pang; R Letourneau; E Webster; G Chrousos
Journal:  Endocrinology       Date:  1998-01       Impact factor: 4.736

9.  Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo.

Authors:  K Karalis; H Sano; J Redwine; S Listwak; R L Wilder; G P Chrousos
Journal:  Science       Date:  1991-10-18       Impact factor: 47.728

10.  Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells.

Authors:  N Fazal; A Slominski; M A Choudhry; E T Wei; M M Sayeed
Journal:  FEBS Lett       Date:  1998-09-18       Impact factor: 4.124

View more
  24 in total

1.  CRH functions as a growth factor/cytokine in the skin.

Authors:  A Slominski; B Zbytek; A Pisarchik; R M Slominski; M A Zmijewski; J Wortsman
Journal:  J Cell Physiol       Date:  2006-03       Impact factor: 6.384

2.  CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes.

Authors:  Blazej Zbytek; Andrzej T Slominski
Journal:  J Invest Dermatol       Date:  2006-10-19       Impact factor: 8.551

Review 3.  Corticotropin releasing hormone and the skin.

Authors:  Andrzej Slominski; Blazej Zbytek; Michal Zmijewski; Radomir M Slominski; Sobia Kauser; Jacobo Wortsman; Desmond J Tobin
Journal:  Front Biosci       Date:  2006-09-01

4.  Neuroendocrinology of the skin: An overview and selective analysis.

Authors:  Michal A Zmijewski; Andrzej T Slominski
Journal:  Dermatoendocrinol       Date:  2011-01

5.  Inhibiting interleukin-18 production through the mitogen-activated protein kinase pathway, a potential role of corticotropin-releasing hormone in chronic plaque psoriasis.

Authors:  Chun-Lei Zhou; Xiao-Jing Yu; Da-Xing Cai; Yong-Hao Xu; Chun-Yang Li; Qing Sun
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 6.  Differential expression of HPA axis homolog in the skin.

Authors:  Andrzej Slominski; Jacobo Wortsman; Robert C Tuckey; Ralf Paus
Journal:  Mol Cell Endocrinol       Date:  2006-12-29       Impact factor: 4.102

7.  On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders.

Authors:  A Slominski
Journal:  Br J Dermatol       Date:  2009-02       Impact factor: 9.302

8.  Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells.

Authors:  Rongjian Zhang; Youhua Xu; Hong Fu; Juejin Wang; Lai Jin; Shengnan Li
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

9.  Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes.

Authors:  Blazej Zbytek; Lawrence M Pfeffer; Andrzej T Slominski
Journal:  J Invest Dermatol       Date:  2003-12       Impact factor: 8.551

10.  Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.

Authors:  Youhua Xu; Rongjian Zhang; Jie Chen; Qichun Zhang; Juejin Wang; Jue Hu; Xiaowei Guan; Lai Jin; Hong Fu; Bo Gui; Yuanyuan Guo; Shengnan Li
Journal:  Br J Pharmacol       Date:  2009-06-30       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.